USPTO serial 79350385
EXPLORASPHERE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 6, 2023
- Examiner
- HSU, FONG
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with EXPLORASPHERE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Maury M. Tepper, III
Maury M. Tepper, III Tepper & Eyster, PLLC3724 BENSON DRRALEIGH, NC 27609UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma | ACTIVE | — |
| 009 | downloadable software for management of patient medical information | ACTIVE | — |
| 010 | Medical and surgical apparatus and instruments for diagnosing and treating cardiovascular diseases; Medical and surgical apparatus and instruments for diagnosing and treating dermatological diseases; medical and surgical apparatus and instruments for diagnosing and treating respiratory diseases and disorders; medical and surgical apparatus and instruments for diagnosing and treating central nervous system diseases; medical and surgical apparatus and instruments for diagnosing and treating gastro-intestinal diseases; medical and surgical apparatus and instruments for the diagnosis, prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; medical and surgical apparatus and instruments for use in hematology and in tissue and organ transplantation; medical and surgical apparatus and instruments for the diagnosis, prevention and treatment of eye diseases and conditions; medical and surgical apparatus and instruments for the diagnosis, prevention and treatment of heart rhythm disorders; medical and surgical apparatus and instruments for the diagnosis, prevention and treatment of immune system related diseases and disorders; medical and surgical apparatus and instruments for the diagnosis, prevention and treatment of kidney diseases; medical and surgical apparatus and instruments for the diagnosis, prevention and treatment of diabetes; medical and surgical apparatus and instruments for the diagnosis, prevention and treatment of hypertension; medical and surgical apparatus and instruments for the diagnosis, prevention and treatment of skin disorders; medical and surgical apparatus and instruments for use in urology; medical and surgical apparatus and instruments for ophthalmological use; medical and surgical apparatus and instruments for the diagnosis, prevention and treatment of cancer and tumors; medical and surgical apparatus and instruments for the diagnosis, prevention and treatment of allergies; medical and surgical apparatus and instruments for the diagnosis, prevention and treatment of bone diseases; medical and surgical apparatus and instruments for the diagnosis, prevention and treatment of respiratory diseases and asthma; radiological apparatus and instruments for medical and surgical use; genetic testing apparatus and instruments for medical use; electromagnetic drug delivery apparatus and instruments for medical use; medical and surgical apparatus and instruments for diagnostic radiopharmaceutical use; medical and surgical apparatus and instruments for facilitating the inhalation of pharmaceutical preparations; apparatus and instruments for DNA and RNA testing for medical and surgical use; medical apparatus, namely, infusion and injection devices for administering drugs; medical and surgical apparatus and instruments for introducing pharmaceutical preparations into the human body | ACTIVE | — |
| 035 | Advertising, marketing and promotional services relating to pharmaceuticals | ACTIVE | — |
| 038 | Providing online chat rooms and electronic bulletin boards for the transmission of messages among users in the fields of healthcare, pharmaceuticals, and developments therein; Transmission of information in the field of pharmaceutical preparations; broadcasting services, namely, transmission of advertising programs and media advertising communications via digital communication networks | ACTIVE | — |
| 042 | Scientific research services; Hosting websites featuring educational content in the field of health | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by NOVARTIS AG
- Other trademarks owned by NOVARTIS AG
- Other trademarks owned by NOVARTIS AG
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 035
- Other trademarks in Class 038
- Other trademarks in Class 042
- Similar marks named EXPLORASPHERE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 4, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 12, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 12, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 6, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 6, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jun 6, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 21, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 21, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 1, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 13, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 7, 2023 | RFNP | REFUSAL PROCESSED BY IB | — |
| Jan 21, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 20, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 20, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 13, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 13, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 13, 2022 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Dec 13, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 13, 2022 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Dec 13, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 13, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 13, 2022 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Nov 2, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 1, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 31, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 4, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 30, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 29, 2022 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Sep 22, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |